# A Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease

> **NCT07593885** · NA · RECRUITING · sponsor: **Dr. Gerhard Mann chem.-pharm. Fabrik GmbH** · enrollment: 160 (estimated)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** Artelac® Complete MDO® Eye Drops
- **DRUG:** VISMED® MULTI Eye Drops

## Key facts

- **NCT ID:** NCT07593885
- **Lead sponsor:** Dr. Gerhard Mann chem.-pharm. Fabrik GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-30
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07593885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07593885, "A Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07593885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*